METTL3 and Dystonia: None of these genes are currently associated with dystonia, but they include ECH1, an enzyme involved in fatty acid metabolism that has been previously identified as a THAP1 target49, and METTL3, the N6-methyladenosine methyltransferase, which is an attractive therapeutic target in cancer50.